Mitochondrial Reactive Oxygen Species in Eye Nerve Damage: Limits, Cleanup Failures, and Precise Treatment Timing

Retinal neurodegenerative diseases may exhibit disease- and stage-specific mitochondrial reactive oxygen species (mtROS) signatures.

• Mitochondrial reactive oxygen species (mtROS) are crucial for redox signaling in healthy retinal cells but can cause damage when their levels exceed regulatory thresholds.
• Subtle changes in mitochondrial redox balance can lead to progressive dysfunction in retinal neurons and supporting cells due to their high energy demands.
• Retinal diseases like glaucoma and diabetic retinopathy are characterized by unique mtROS patterns influenced by the capacity for mitochondrial quality control.
• Current antioxidant treatments often fail because they indiscriminately suppress oxidative species instead of targeting specific mitochondrial functions.
• Emerging therapies focus on restoring mitochondrial redox balance tailored to disease stage and cellular conditions rather than completely eliminating mtROS signaling.
• A proposed framework integrates mtROS regulation with mitochondrial quality control to identify critical therapeutic windows for treatment.

Simplified